Literature DB >> 22895891

Open-lung biopsy in patients with undiagnosed lung lesions referred at a tertiary cancer center is safe and reveals noncancerous, noninfectious entities as the most common diagnoses.

S P Georgiadou1, F L Sampsonas, D Rice, J M Granger, S Swisher, D P Kontoyiannis.   

Abstract

We evaluated the diagnostic yield of open-lung biopsies (OLBs) in a large tertiary cancer center to determine the role of infectious diseases as causes of undiagnosed pulmonary lesions. All consecutive adult patients with either single or multiple pulmonary nodules or masses who underwent a diagnostic OLB over a period of 10 years (1998-2007) were retrospectively identified. Their risk factors for malignancy and clinical and radiological characteristics were reviewed, and their postoperative complications were assessed. We evaluated 155 patients with a median age of 57 years (range, 19-83 years). We identified infectious etiologies in 29 patients (19 %). The most common diagnosis in this group was histoplasmosis (12 [41 %]), followed by nontuberculous mycobacterial infection (7 [24 %]) and aspergillosis (4 [14 %]). The majority of the 126 remaining patients had nonmalignant diagnoses, the most prevalent being nonspecific granuloma (26 %), whereas only 17 % had malignant diagnoses. We observed no significant differences among the patients with infectious, malignant, or both noninfectious and nonmalignant final diagnoses regarding their demographic, laboratory, and clinical characteristics. Six percent of the patients had at least one post-OLB complication, and the post-OLB mortality rate was 1 %. OLB is a safe diagnostic procedure which frequently identifies a wide variety of infectious and inflammatory diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22895891      PMCID: PMC3855420          DOI: 10.1007/s10096-012-1720-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  31 in total

1.  Four cases of pulmonary Mycobacterium avium intracellulare complex presenting as a solitary pulmonary nodule and a review of other cases in Japan.

Authors:  Yoshihiro Kobashi; Minoru Fukuda; Kouichiro Yoshida; Naoyuki Miyashita; Yoshihito Niki; Mikio Oka
Journal:  Respirology       Date:  2006-05       Impact factor: 6.424

2.  Solitary pulmonary nodules: pathological outcome of 150 consecutively resected lesions.

Authors:  Ben Davies; Sudip Ghosh; David Hopkinson; Roger Vaughan; Gaetano Rocco
Journal:  Interact Cardiovasc Thorac Surg       Date:  2004-12-17

3.  Antibiotic use in the management of pulmonary nodules.

Authors:  Saira Khokhar; Svetlana Mironov; Venkatraman E Seshan; Diane E Stover; Rohit Khirbat; Marc B Feinstein
Journal:  Chest       Date:  2009-09-25       Impact factor: 9.410

4.  Etiology of solitary pulmonary nodules in patients with human immunodeficiency virus infection.

Authors:  F J Martínez-Marcos; P Viciana; E Cañas; J Martín-Juan; I Moreno; J Pachón
Journal:  Clin Infect Dis       Date:  1997-05       Impact factor: 9.079

5.  Glossary of terms for thoracic radiology: recommendations of the Nomenclature Committee of the Fleischner Society.

Authors:  W J Tuddenham
Journal:  AJR Am J Roentgenol       Date:  1984-09       Impact factor: 3.959

6.  Paragonimiasis westermani presenting as an asymptomatic nodular lesion in the lung: report of a case.

Authors:  I Yoshino; Y Nawa; T Yano; Y Ichinose
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

7.  The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules.

Authors:  S J Swensen; M D Silverstein; D M Ilstrup; C D Schleck; E S Edell
Journal:  Arch Intern Med       Date:  1997-04-28

8.  Computed tomography-guided percutaneous needle biopsy of indeterminate pulmonary pathology: efficacy of obtaining a diagnostic sample in immunocompetent and immunocompromised patients.

Authors:  Nishita Kothary; Jason A Bartos; Gloria L Hwang; Ruchika Dua; William T Kuo; Lawrence V Hofmann
Journal:  Clin Lung Cancer       Date:  2010-07-01       Impact factor: 4.785

9.  Bartonella henselae: etiology of pulmonary nodules in a patient with depressed cell-mediated immunity.

Authors:  M A Caniza; D L Granger; K H Wilson; M K Washington; D L Kordick; D P Frush; R B Blitchington
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

10.  Diagnostic yield of transthoracic needle aspiration biopsy following negative fiberoptic bronchoscopy in 103 patients with peripheral circumscribed pulmonary lesions.

Authors:  N Milman; P Faurschou; G Grode
Journal:  Respiration       Date:  1995       Impact factor: 3.580

View more
  5 in total

1.  The diagnostic yield and complications of open lung biopsies in kidney transplant patients with pulmonary disease.

Authors:  Daniere Yurie Vieira Tomotani; Antônio Tonete Bafi; Eduardo Souza Pacheco; Tainá Veras de Sandes-Freitas; Laila Almeida Viana; Edgar Porto de Oliveira Pontes; Nikkei Tamura; Hélio Tedesco-Silva; Flavia Ribeiro Machado; Flávio Geraldo Rezende Freitas
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

2.  Clinical and radiographic differentiation of lung nodules caused by mycobacteria and lung cancer: a case-control study.

Authors:  Cesar J Figueroa; Elyn Riedel; Michael S Glickman
Journal:  BMC Infect Dis       Date:  2015-10-28       Impact factor: 3.090

3.  Evaluating the Prognostic Role of Monocytopenia in Chemotherapy-Induced Febrile Neutropenia Patients Treated with Granulocyte Colony-Stimulating Factor.

Authors:  Osama Alshari; Yazan O Al Zu'bi; Ahmed H Al Sharie; Farouk H Wafai; Abdelwahab J Aleshawi; Farah H Atawneh; Hasan A Obeidat; Majd N Daoud; Mohammad Z Khrais; Dima Albals; Faize Tubaishat
Journal:  Ther Clin Risk Manag       Date:  2021-09-07       Impact factor: 2.423

4.  Pulmonary histoplasmosis presenting with a halo sign on CT in an immunocompetent patient.

Authors:  Graziella Hanna Pereira; Liliane Yuri Almeida; Rosa Shizuda Okubo; Edson Marchiori
Journal:  J Bras Pneumol       Date:  2013 Jun-Aug       Impact factor: 2.624

5.  Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  G Maschmeyer; J Carratalà; D Buchheidt; A Hamprecht; C P Heussel; C Kahl; J Lorenz; S Neumann; C Rieger; M Ruhnke; H Salwender; M Schmidt-Hieber; E Azoulay
Journal:  Ann Oncol       Date:  2014-05-15       Impact factor: 32.976

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.